Nuvation Bio
NUVB
NUVB
129 hedge funds and large institutions have $228M invested in Nuvation Bio in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.07% less ownership
Funds ownership: 64.19% → 63.12% (-1.1%)
15% less capital invested
Capital invested by funds: $267M → $228M (-$39.1M)
Holders
129
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$10.2M | |
| 2 | +$1.49M | |
| 3 | +$617K | |
| 4 |
NYLIM
New York Life Investment Management
New York
|
+$472K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$468K |
Top Sellers
| 1 | -$9.23M | |
| 2 | -$4.53M | |
| 3 | -$4.08M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.08M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$831K |